Tag Johnson & Johnson

During the September Monthly Meeting , we took questions straight from Investing Club members. Here are Jim Cramer’s and portfolio director Jeff Marks’ responses. Their solutions have been edited for

Continue ReadingMonthly Meeting Q&A with Jim Cramer on 20 stocks in everything from tech to health care to retail

US President Donald Trump (R) gestures as he talks with US Ambassador to the United Kingdom Woody Johnson (L) getting ready to board Marine One to depart the US ambassador’s

Continue ReadingJets owner Woody Johnson is privately lobbying GOP megadonors to donate to Trump’s campaign

Here’s our Club Mailbag electronic mail investingclubmailbag@cnbc.com — so that you ship your questions on to Jim Cramer and his crew of analysts. We cannot provide private investing recommendation. We

Continue ReadingHow breakups impact shareholders, market vs. limit orders — we’ve got answers

© 2023 CNBC LLC. All Rights Reserved. A Division of NBCUniversal Data is a real-time snapshot *Data is delayed at the very least quarter-hour. Global Business and Financial News, Stock

Continue Reading4 moments from Jim Cramer’s August Monthly Meeting of the CNBC Investing Club

Merck & Co. Inc. Januvia model medicine, used to deal with type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is

Continue ReadingThese 10 medications are likely targets for Medicare price negotiations this fall

Medical syringes and Novavax brand displayed within the background are seen on this illustration photograph taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images

Continue ReadingNovavax shares jump after Covid vaccine maker posts surprise quarterly profit

(*5*)In a jam-packed week of earnings, the Club executed a number of trades and elevated worth targets for a few of our greatest shares. Many of those strikes stemmed from

Continue ReadingHere are the 5 price-target changes and 4 trades we made during this busy earnings week

Kenvue, a unit of Johnson & Johnson’s client well being enterprise. CFOTO | Future Publishing | Getty Images Johnson & Johnson on Monday stated it plans to reduce by at

Continue ReadingJohnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer

If you had to ask me what the bears obtained most unsuitable, it is fairly easy: Federal Reserve Chairman Jerome Powell’s exceptional skill to divine the second and do the

Continue ReadingHere’s what the bears are lacking, and why there’s still money to be made in this bull market

Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health enterprise, speaks throughout an interview to have fun its IPO on the New York Stock Exchange (NYSE), May 4,

Continue ReadingKenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas